A therosclerosis may be the result of genetic susceptibility combined with environmental factors, such as diet, lifestyle, and/or possibly microbial infections. 1, 2 Oxidized LDL, one of the factors thought to affect vessel wall integrity, 3 can lead to an inflammatory response. 4 Such a response will induce endothelial cell activation, extravasation of leukocytes, and a migratory/reparative process by vascular smooth muscle cells (SMCs). 5 Activated endothelium will express, in sequence, a series of adhesion molecules and powerful cofactors, such as growth factors, cytokines, or NO, which will tether and activate integrin complexes, initiate de novo gene transcription, and allow the extravasation of monocytes or T lymphocytes. 6 These adhesion molecules include intercellular adhesion molecule-1 (ICAM-1 or CD54), 7 platelet-endothelial cell adhesion molecule-1 (PECAM-1 or CD 31), 8 vascular cell adhesion molecule-1 (VCAM-1 or CD106), 9 and P-selectin (CD 62P). 10 Genetic variation at the apoE locus in humans is associated with hyperlipidemia and premature atherosclerotic risk. 11 Recently, apoE-null (apoE Ϫ/Ϫ ) mice, generated by gene targeting, 12 have been shown to develop pronounced hypercholesterolemia and atherosclerotic lesions 13 with certain fea-tures resembling those seen in humans 14, 15 and other species. 16 These mice have become accepted as an animal model for the study of factors involved in atherogenesis. 17 However, for this model, little is known about the expression of the endothelial adhesion molecules that are implicated in human atherosclerosis.
In the present study, the mean expression of adhesion molecules, lining the whole vessel intimal circumference, over a period of time (0 to 20 weeks of diet) was quantitatively assessed in apoE Ϫ/Ϫ mice (C57BL/6 background) and wild-type mice fed a chow or a cholesterol-rich diet. Results showed first an increase (at 6 weeks) and then a reduction (at 16 weeks) in ICAM-1 and PECAM-1 (PϽ0.05) levels in apoE Ϫ/Ϫ but not in wild-type animals. In the second part of the study, we assayed the levels of adhesion molecules in different types of histologically defined atherosclerotic lesions in apoE Ϫ/Ϫ animals fed for 20 weeks. All 3 adhesion molecules (ICAM-1, PECAM-1, and VCAM-1) were observed to be reduced in fibrofatty and complex lesions but not in fatty streaks or adjacent to areas without lesions.
Methods

Animal Handling
Surgical procedures and animal care strictly conformed to the Guidelines of the National Institute of Health and Medical Research (decree No. 87-848, October 19, 1987) . All animals used in this study were ether-anesthetized before organ sampling.
Mice
The apoE m1Unc line was obtained from Dr N. Maeda (University of North Carolina, Chapel Hill). Control C57BL/6JIco and apoEdeficient mice (C57BL/6JIco background) were backcrossed, bred, and housed under specific and opportunistic pathogen-free conditions by Transgenic Alliance (Iffa Credo S.A., a Charles River Co, Lyon, France). Control (nϭ45) and apoE-deficient (nϭ45) mice were weaned at 3 weeks of age and maintained on a chow diet for 1 week ("Souriffarat" breeding diet, standard formulation, pellets, irradiated at 25 kGy, from Extralabo). After that stage, they either had access to a chow diet (4% fat, 0% cholesterol) or a Western-type diet (21% fat, 0.15% cholesterol, special high fat formulation powder, irradiated at 25 kGy). Basal observations were made in 3-week-old weaned control or apoE-deficient mice. All animals received water and food ad libitum during the 3-, 6-, 16-, and 20-week schedules.
Cholesterol Level Analysis in ApoE-Deficient and Wild-Type Mice
This section can be accessed online at www.ahajournals.org.
Organ Isolation and Preparation for Immunohistochemistry and Molecular Biology Techniques
Validation of All Types of Vascular Lesions and Intimal/Media Thickness Ratio
Immunohistochemistry
Five serial sections were immunostained and quantitatively analyzed for each animal. Briefly, one of these 5 sections, originating from apoE and C57BL6 animals at different time periods (0 to 20 weeks), was simultaneously stained as described online at www.ahajournals.org. In addition, 3 positive and 3 negative controls were present in all staining series. Finally, calibration of the Leica image analyzer, for the whole study, was kept at the same original setting. The following primary monoclonal antibodies were used for immunohistochemical studies. Anti-mouse PECAM-1 (rat IgG2a, 50 g/mL), anti-mouse VCAM-1 (rat IgG2a, 5 g/mL), and the nonimmune IgG (rat IgG2a, 5 g/mL) were purchased from Pharmingen. Anti-mouse ICAM-1 (rat IgG2a, 4 g/mL) was obtained from Seikagaku Co. Anti-␣-actin monoclonal antibody (mouse IgG2a, 5 g/mL) was from Boehringer-Mannheim, and anti-mouse macrophage (rat IgG2b, 5 g/mL) was from Serotec. Endothelial cells were identified through the use of an anti-human von Willebrand factor (rabbit polyclonal), which was purchased from Dako. Antibodies were detected as described online at www.ahajournals.org. A nonimmune IgG was used at the place of the primary antibodies as a negative control. A nuclear counterstaining with hematoxylin followed immunohistochemistry for the identification of macrophages and SMCs.
Image Analysis
Endothelial layer staining of the aortic arch sections was quantified by using a color image analyzer (Quantimet 600 Leica analyzer) according to the technique described by Poston et al. 7 The technique used is described online at www.ahajournals.org.
Data Comparisons
The Student test or 1-way ANOVA was performed with the use of StatView 4.02 software (Abacus Concept, Inc). Results are expressed as meanϮSEM, and a value of PϽ0.05 was considered significant.
Total RNA Isolation
Aortas and aortic arches from C57BL6 and apoE Ϫ/Ϫ mice (nϭ64), isolated at different periods of time (0, 6, 16, and 20 weeks), were snap-frozen in liquid nitrogen and stored at Ϫ80°C. Total RNA was extracted from each individual mouse at the indicated times (nϭ8). Briefly, frozen tissue was ground in a mortar in liquid nitrogen. The frozen powdered sample was immediately mixed with TRIzol (Gibco BRL, Life Technologies) and homogenized with a Polytron (Brinkmann). Total RNA was extracted by using the TRIzol method adapted from the procedure of Chomczynski and Sacchi. 18 
Probe Synthesis and Labeling
The 625-bp ICAM probe was prepared by reverse transcription (RT)-polymerase chain reaction (PCR) by use of the following primers: ICAM1390U (CATCGGGGTGGTGAAGTCTGT) and ICAM1996L (TGTCGGGGGAAGTGTGGTC). RT-PCR amplification, labeling, and purification are described online at www.ahajournals.org.
Northern Blots
Total RNA (20 g) was denatured, separated by electrophoresis on a formaldehyde-MOPS-agarose gel, and then transferred to a nylon membrane (Hybond Nϩ, Amersham). Capillary blotting was performed overnight, and then the membrane was baked for 2 hours at 80°C. Prehybridization and hybridization were performed according to standard protocols. 19 Blots were exposed against a PhosphorImager screen (Molecular Dynamics) for 24 hours. Scanning was performed under a 100-scale, and the ImageQuant software was then used for quantification. Variations in RNA loading were assessed by using the GAPDH probe (Clontech), which allowed normalizing ICAM-1 values. All quantification values were corrected for background levels by using the local median method of the ImageQuant software. The initial scan image (gel format) was transferred into a tif file to provide the Northern blot figures presented in this article.
RT-PCR Analysis of VCAM-1
RNA-extracted aortas of C57BL6 and apoE mice were treated with DNase I to remove genomic contamination (MessageClean, GenHunter). Removal of DNA was verified by performing a PCR, with use of GAPDH as well as VCAM-1 primers, on the extracted RNA (or an RT-PCR without the addition of the reverse transcriptase enzyme). Absence of these transcripts confirmed efficient removal of genomic DNA. The 375-bp GAPDH cDNA was obtained by using the following primers: GPDH-793U21 (ACCTGCCAAGTATGAT-GACAT) and GPDH-1148L21 (CCTGTTATTATGGGGGTCTG).
The 447-bp VCAM-1 cDNA was obtained by using the following primers: VCAM-1660U21 (CAGCTAAATAATGGGGAACTG) and VCAM-2088L19 (GGGCGAAAAATAGTCCTTG). The RT-PCR conditions were the same as for the synthesis of the ICAM-1 probe (see above).
Results
Qualitative Results
Qualitative results, with use of immunohistochemical techniques, were obtained with antibodies directed against ICAM-1, PECAM-1, and VCAM-1. Endothelial cells were identified with an anti-von Willebrand factor monoclonal antibody ( Figure 1A and 1B) . Such von Willebrand factor labeling allowed the correlation of the endothelial layer staining with monoclonal antibodies directed against adhesion molecules. ICAM-1 was strongly expressed in regions adjacent to the lesions but weakly expressed on endothelial cells overlying fibrofatty or complex lesions ( Figure 1C and 1D). Moreover, SMCs proliferating within the atherosclerotic lesions also expressed ICAM-1. PECAM-1 was qualitatively observed to be expressed by endothelial cells ( Figure 1E and 1F). Endothelial cells overlying fibrofatty and complex lesions weakly expressed VCAM-1. However, the shoulder of lesions expressed VCAM-1. In addition, VCAM-1 was also seen to be expressed by SMCs proliferating within the atherosclerotic lesions ( Figure 1G and 1H).
Quantitative Results
Quantitative results, obtained from image analysis of stained sections, are presented in 2 main parts: (1) the mean expression of endothelium adhesion molecules, lining the whole vessel circumference, over a period of time (0 to 20 weeks of diet in chow-or fat-fed apoE Ϫ/Ϫ compared with wild-type animals), and (2) the mean expression of adhesion molecules, correlated with the different types of histologically defined vascular lesions, in 20-week fat-fed apoE Ϫ/Ϫ mice.
Mean Expression of Adhesion Molecules Over Time (0 to 20 Weeks of Diet)
Background expression of adhesion molecules was calculated from the mean of ICAM-1, PECAM-1, and VCAM-1 expression by endothelial cells, which were present all around the intimal vessel circumference. ApoE Ϫ/Ϫ mice (nϭ5) were compared with C57BL/6 mice (nϭ5) over a period of time (0 to 20 weeks of the chow or fat diet, Figure 2 and Figures I, II, III, which can be accessed online at www.ahajournals.org).
The apoE Ϫ/Ϫ mice weaned at 3 weeks of age (no diet) showed moderate expression of ICAM-1 (Figure 2A ). ICAM-1 expression was strongly increased (PϽ0.001) in the endothelium of apoE Ϫ/Ϫ animals fed either diet for 3 or 6 weeks compared with weaned mice. Compared with 6 weeks, after 16 or 20 weeks of either diet, ICAM-1 expression was significantly reduced (PϽ0.001). Such lower ICAM-1 expression was particularly significant in apoE Ϫ/Ϫ animals fed a fat diet. In contrast, C57BL/6 mice showed a steady expression of ICAM-1 from 3 to 20 weeks, irrespective of diet. C57BL/6 mice on a fat diet, compared with those on a chow diet, showed a slight but significant (PϽ0.001) increase in ICAM-1 expression ( Figure 2B) .
A high basal PECAM-1 expression, measured in the endothelium of the apoE Ϫ/Ϫ mice weaned at 3 weeks of age (no diet), was observed. Moreover, upregulated expression of PECAM-1 (PϽ0.05) was observed for apoE Ϫ/Ϫ animals on either diet for 3 weeks. In addition, after 6 weeks of the chow diet, endothelial PECAM-1 expression was significantly (PϽ0.05) increased. PECAM-1 expression was significantly decreased (PϽ0.001) for apoE Ϫ/Ϫ animals fed a chow diet for 16 and 20 weeks compared with those fed a chow diet for 6 weeks ( Figure 2C ). C57BL/6 mice showed a major increase (PϽ0.001) in PECAM-1 expression after 3 weeks of either type of diet compared with weaned mice. Then, after 6 to 20 weeks of either diet, the expression of PECAM-1 was found to be more or less steady. One should note a consistently higher level of PECAM-1 expression (PϽ0.05) in the fat-fed compared with the chow-fed animals ( Figure I , which can be accessed online at www.ahajournals.org).
VCAM-1 basal expression, measured in the endothelium of the weaned apoE Ϫ/Ϫ mice (3 weeks of age and no diet), showed variable levels. VCAM-1 expression did not show a significant modulation pattern, as was observed for ICAM-1 and PECAM-1. Moreover, the VCAM-1 expression levels were consistently lower compared with those of ICAM-1 and PECAM-1. No significant differences in VCAM-1 expression were observed between apoE animals fed a fat or chow diet ( Figure II , which can be accessed at www.ahajournals.org). In addition, compared with weaned mice, wild-type mice showed no significant changes in VCAM-1 expression by endothelial cells over time ( Figure III , which can be accessed online at www.ahajournals.org). mice (nϭ5) fed a fat diet for 20 weeks or apoE Ϫ/Ϫ animals (nϭ5) aged 3 weeks of age that were not on a diet ( Figure  3 and Figure IV , which can be accessed online at www.ahajournals.org).
Mean Expression of Adhesion Molecules Correlated With
ICAM-1 expression in weaned animals not on a diet was low ( Figure 3A) . In contrast, in animals fed 20 weeks of the fat diet, compared with weaned animals, ICAM-1 expression The expression of ICAM-1 (nϭ45), VCAM-1 (nϭ45), and PECAM-1 (nϭ45) by the endothelium all around the vessel circumference was quantified by using a color image Quantimet 600 Leica analyzer. The analysis was displayed by use of a ϫ40 objective. Results are expressed as meanϮSEM of 6 to 24 measurements obtained from 5 individuals per group. *Significantly different from week 0. A, Expression of ICAM-1 was significantly increased (PϽ0.001) between weaned apoE Ϫ/Ϫ mice (represented by 0) and animals fed either diet for 3 or 6 weeks. However, at 16 and 20 weeks, compared with 6 weeks, the expression is reduced. ICAM-1 expression, at 16 and 20 weeks, was comparable to that of weaned animals for fat-fed apoE Ϫ/Ϫ mice but significantly higher for chow-fed apoE Ϫ/Ϫ animals (PϽ0.001). B, In the C57BL6 mice, there was a steady expression of ICAM-1 from 3 to 20 weeks, irrespective of diet. On the other hand, there was a slight but significant (PϽ0.001) increase in ICAM-1 expression in fat-fed compared with chow-fed C57BL6 animals. This increase was unchanged from 3 to 20 weeks. C, Expression of PECAM-1 was significantly increased (PϽ0.05) between weaned apoE Ϫ/Ϫ mice and mice fed 3 weeks of either diet. At 6 weeks, only chow-fed apoE Ϫ/Ϫ mice showed an enhanced expression (PϽ0.05). However, at 20 weeks of diet, the expression was significantly (PϽ0.05) decreased in fat-fed apoE Ϫ/Ϫ compared with weaned mice.
was significantly elevated in areas with no lesions. This high level of ICAM-1 expression, associated with histologically identified atherosclerotic lesions, was also present in endothelium overlying fatty streaks. However, ICAM-1 levels were significantly (PϽ0.05) reduced in fibrofatty and complex lesions compared with areas with no lesions ( Figure 3A) . PECAM-1 expression by endothelium from weaned animals was very high. No difference was observed between areas showing no lesions or fatty-streak lesions. In contrast, PECAM-1 expression was significantly reduced in endothelial cells overlying fibrofatty or complex lesions compared with areas with no lesions ( Figure IV , which can be accessed online at www.ahajournals.org).
VCAM-1 expression by endothelium from weaned animals was low ( Figure 3B ). VCAM-1 levels in histologically identified lesions in animals fed 20 weeks of the fat diet were markedly increased (PϽ0.05) in the endothelium overlying the fatty streaks and decreased in a very significant way (PϽ0.001) in fibrofatty or complex lesions compared with areas with no lesions.
Northern Blots
Confirmation of immunohistochemical results on ICAM-1 was obtained by Northern blots performed on aortic arch samples of apoE and C57BL6 chow-fed mice over a period of 20 weeks. Samples from 8 different animals (C57BL6 and apoE) at different time points (0, 6, 16, and 20 weeks) were separately investigated ( Figure 4A ). This overall analysis of aortic arch samples was performed on a total of 64 animals. Results show that ICAM-1, in aortic arch samples of apoE mice at 6 weeks of chow diet, is upregulated (by at least 2-fold) compared with C57BL6 and apoE animals at 0 and 16 weeks ( Figure 4B ). However, an increase in ICAM-1 transcription was observed in the aortic arch at 20 weeks. There was no particular pattern for ICAM-1 expression in C57BL6. The present study shows for the first time, with use of Northern blots, that the ICAM-1 transcription level is modulated in the aortic arch of 6-week chow-fed apoE but not C57BL6 mice. One should note that Northern blot results are obtained from RNAs extracted from whole vessels. In contrast, immunohistochemistry is performed on endothelial cells lining the vessel wall.
RT-PCR Analysis of VCAM-1
In the present study, we report for the first time the presence of VCAM-1 mRNA transcripts in murine aortas at different periods of time ( Figure 5A ). The presence of VCAM-1 mRNA was tested by RT-PCR on aortas, aortic arches, and hearts of C57BL6 and apoE mice. All these tissues showed the presence of VCAM-1 mRNA after genomic DNA removal ( Figure 5B) . A GAPDH-positive control in the RT-PCR experiments is shown in Figure V (which can be accessed online at www.ahajournals.org). The abovementioned VCAM-1 data confirm that detection of VCAM-1 by immunological methods is not a background noise. These observations are very much in line with those obtained by immunological techniques as shown in the present study.
Discussion
The present study reports, for the first time, a quantitative analysis of major adhesion molecules expressed by endothelial cells from the aortic arch of apoE-deficient mice compared with wild-type mice (C57BL/6). The following results were observed: (1) The mean expression of 2 major vascular adhesion molecules (ICAM-1 and PECAM-1), lining the whole intimal vessel circumference, over a period of time (0 to 20 weeks of diet) is modulated in the atherosclerotic lesions of apoE Ϫ/Ϫ mice but not in C57BL/6 control mice. Confirmation of immunohistochemical results on ICAM-1 was obtained by Northern blots performed on the aortas of apoE and C57BL6 chow-fed mice over a period of 20 weeks. ( 2) The intensity of expression of 3 major vascular adhesion molecules (ICAM-1, PECAM-1, and VCAM-1) by the endothelium, lining different types of histologically defined atherosclerotic lesions after 20 weeks of diet, is correlated with the progression and severity of atherosclerotic lesions. In line animals (nϭ5) and animals after 20 weeks of fat diet. Ten to 53 measurements per mouse were used for the analysis of the 3 adhesion molecules expressed by the endothelium over the described areas. A, ICAM-1 showed a low expression in weaned mice (no diet). ICAM-1 expression was significantly elevated in areas with no lesions in apoE Ϫ/Ϫ animals fed 20 weeks of fat diet compared with weaned mice. This high level of ICAM-1 expression, associated with histologically identified atherosclerotic lesions, was also present in endothelium overlying fatty streaks. However, fibrofatty plaques and complex lesions showed a significant decrease of ICAM-1 expression (PϽ0.05) compared with areas with no lesions. B, VCAM-1 expression levels in the endothelium of weaned apoE Ϫ/Ϫ mice were quite variable. Fatty streak areas, obtained from apoE Ϫ/Ϫ mice fed 20 weeks of fat diet, showed significantly increased levels of VCAM-1 compared with areas with no lesions. With the increased severity of atherosclerosis, VCAM-1 expression was diminished (PϽ0.001 and 0.05), compared with areas with no lesions, in the endothelium of 20-week fat-fed apoE Ϫ/Ϫ mice.
with previously published data, our results involving atherosclerotic lesions are characterized by typical lipid deposition, cellular infiltration, and SMC proliferation. 14, 20 In addition, plasma cholesterol levels and an increase of the intima/media ratio, significantly higher in apoE Ϫ/Ϫ compared with wildtype animals, did vary with the type of diet used.
Atherosclerotic lesions may be the result of some form of inflammation, induced by the presence of oxidized LDL, Chlamydia pneumoniae, 21 or viral or other factors, occurring at the level of the vessel wall. 22 Vascular endothelial cells, activated at sites of inflammation, interact with different leukocyte subtypes via adhesion molecules and different cofactors and are thought to play a key role in the initiation and perpetuation of atherosclerotic lesions. 23, 24 Among a number of adhesion molecules implicated in the homing of leukocytes to sites of inflammation, endothelial ICAM-1 and its leukocyte ligand CD11a/CD18 (also known as ␣ L ␤ 2 or lymphocyte function-associated antigen-1) play a major role in this process. 25, 26 In the present study, a significant modulation of ICAM-1 expression over time by endothelial cells lining the whole vessel wall circumference was observed for the aortic arch region of apoE-deficient mice fed a fat or chow diet. Northern blots on aortic arch samples, for determination of ICAM-1 gene expression, showed an increase at 6 weeks (by at least 2-fold) compared with 0 and 16 weeks in C57BL6 and apoE animals. However, an increase in ICAM-1 transcription was observed in the aortic arch at 20 weeks. These Northern data results are in line with those obtained by immunohistochemistry at 0, 6, and 16 weeks but not at 20 weeks. One should note that Northern blots are performed on whole vessels, whereas immunohistochemistry was performed on endothelial cells lining the vessel circumference. Additional transcription of ICAM-1 may take place in other cells, such as SMCs, present in the vessel. It is interesting that such an increase of ICAM-1 transcription levels at 20 weeks in aortic arch samples is not present in aortas (data not shown). Reduced endothelial ICAM-1 expression coincided with the presence of a significant number of more advanced fibrotic lesions. A decrease in ICAM-1 expression may be matched with a reduced influx of leukocytes within atherosclerotic walls. Indeed, Roselaar et al 27 indicate that the number of T lymphocytes, immunoreactive for Thy 1.2, CD4, CD5, and CD8, in atherosclerotic lesions of 16-week-old apoE Ϫ/Ϫ and LDL receptor-deficient mice is very significantly decreased from the levels present in 4-week-old mice. Interestingly, blocking the access of ICAM-1 to leukocytes by monoclonal antibodies in apoE-deficient animals on a chow diet reduced the homing of macrophages to atherosclerotic plaques by 65%. 28 Our results are supported by a recent study that used qualitative analysis and reported increased ICAM-1 expression in apoE-deficient animals. 29 Moreover, and very significantly, observations made on human coronar- ies and carotids show ICAM-1 expression to be correlated with vascular lesions. 7 ICAM-1, as well as VCAM-1, is expressed in a flow-dependent manner. 30 Upregulation of ICAM-1 from its constitutive levels of expression on cultured human and rabbit arterial endothelial cells has been shown to occur after lysophosphatidylcholine treatment. 31 Moreover, lysophosphatidylcholine induced the expression of ICAM-1 on endothelium derived from human iliac arteries but not from umbilical veins. 31 It is of interest to note that high levels of lysophosphatidylcholine are present in a hyperlipidemic state.
Endothelial adhesion molecules, together with other important cofactors, such as chemoattractants, play a critical role in the homing of monocytes to sites of vascular lesions. In apoE Ϫ/Ϫ compared with wild-type animals, a significant modulation of ICAM-1 expression over time is observed. Other factors, in addition to adhesion molecules, appear to be implicated in the swift initiation and perpetuation of vascular lesions. Indeed, knocking out monocyte chemoattractant protein-1 (MCP-1) or its receptor, in LDL receptor-deficient or apoE Ϫ/Ϫ mice, respectively, will also significantly decrease lesion formation. 32, 33 Blocking nuclear factor-B activity in endothelial cells by anti-sense oligonucleotides will affect not only ICAM-1 upregulation but also MCP-1 production and, ultimately, the homing of monocytes. 34 Adhesion and transmigration, mediated by several interacting molecular mechanisms, appear to be essential for monocyte traffic in atherosclerosis. Some of these factors, such as nuclear factor-b, MCP-1, interleukin-8/neutrophil-activating peptide, plateletactivating factor, and RANTES, may be activated or upregulated at an early stage in apoE Ϫ/Ϫ but not wild-type mice. PECAM-1 is one of the most abundant constitutively expressed endothelial cell adhesion molecules (up to 10 6 molecules per cell). 7 There is good evidence to suggest that it is a key participant in the adhesion cascade leading to extravasation of leukocytes to sites of inflammation. 35 However, the mechanism explaining PECAM-1 implication in leukocyte transmigration is not yet completely elucidated. PECAM-1 molecules expressed by leukocytes and endothelial cells are known to allow homophilic interactions. 36 In addition, it has been suggested that PECAM-1 can interact with upregulated ␣ v ␤ 3 . 37, 38 In the present study, a significant modulation of endothelial PECAM-1 expression, lining the whole vessel wall circumference, was observed for apoEdeficient but not wild-type mice. It is of interest to note that PECAM-1 expression can be significantly modulated after treatment of human umbilical vein endothelial cells with inflammatory cytokines. Indeed, tumor necrosis factor-␣ and interferon-␥ can lead to the disappearance of PECAM-1 from cell junctions and a very significant reduction in the migration of leukocytes through endothelial cells. 39 In a recently published report 31 on apoE, it was stated that PECAM-1 appears not to be differentially regulated. Differences between our results and those of Nakashima et al 29 may conceivably be due to the fact that we have used a quantitative technique to assay the mean expression level of PECAM-1. It is conceivable that the increased expression of PECAM-1 and ICAM-1 is the result of either a continuous insult of endothelial cells or repeated insult and injury, which may result in endothelial cell regeneration. 1 Albelda et al 35, 36 inhibited in vitro confluence of cultured endothelial cells by using anti-PECAM-1 antibodies. Such data strongly indicate that PECAM-1, through its homotypic mechanism of adhesion, is actively involved in the regulation of cell-cell adhesion. 36 The cooperation between adhesion molecules may enhance cell-cell cross talk and subsequent interactions. It was recently suggested that homophilic adhesion of PECAM-1 might lead to integrin upregulation. 40 Endothelial VCAM-1, an inducible cell surface adhesion molecule of the immunoglobulin gene superfamily, interacts with cells expressing the integrin ␣ 4 ␤ 1 ligand. 41 VCAM-1 has been identified as a very early event in the development of atherosclerotic lesions in experimental animal models. 42 Our results show that over time the profile of endothelial VCAM-1 mean expression, lining the whole vessel intimal circumference, did not significantly change for either apoE Ϫ/Ϫ or wild-type mice. However, endothelial VCAM-1 was highly expressed over fatty streaks and was decreased on fibrofatty and complex lesions. In our samples, VCAM-1 not only was identified on endothelial cells but also was present on proliferating SMCs. These data report for the first time the presence of VCAM-1 mRNA levels in murine control C57BL6, as well as apoE, aortas. All murine tissues tested (aortas, aortic arches, and hearts) showed the presence of VCAM-1 mRNA after genomic DNA removal. Great care should be taken in the selection of primers, PCR product length, and PCR conditions to be able to detect murine VCAM-1 mRNA. These observations are very much in line with those obtained with the use of immunological techniques, as shown in the present study and in those reported by a number of authors. In fact, by use of in vivo radiolabeled monoclonal antibody techniques, constitutive murine (C57BL/6Jstrain) VCAM-1 expression was shown to be present in the heart vasculature. Moreover, murine constitutive VCAM-1 expression is quite heterogeneous, with the highest level present in the heart, followed by the mesentery, brain, and small intestine. 43 Another study showed the presence of constitutive VCAM-1 expression by the endothelium of the coronary artery and the endocardium in C57BL/6 mice. 44 In addition, scattered endothelial cells in normal murine aorta express VCAM-1. 45 Moreover, Ando et al 46 demonstrated that cultured murine endothelial cells show constitutive high levels of VCAM-1 expression. Furthermore, Li et al 47 found similar results within arteriosclerotic plaques from rabbits fed a 0.3% cholesterol-containing diet. Moreover, a recent study involving apoE-deficient mice 31 very much supports the present observations. In human tissues, different workers showed VCAM-1 expression to be either present or weakly detected in atherosclerotic lesions. To explain such discrepancies, it is conceivable that lesions examined by different teams may have been at slightly different stages of evolution of the plaque or ages of the patients. De novo expression of VCAM-1 may be induced, as it is for ICAM-1, by the generation of lysophosphatidylcholine during hyperlipidemia, leading preferentially for mononuclear recruitment to sites of atherogenesis. 48 Finally, VCAM-1 may play a vital role in the vasa vasorum, by modulating the extravasation of leukocytes. 11, 25 One possible way to investigate the role of adhesion molecules in initiating and perpetuating vascular lesions over time is by measuring their mean expression level present around the whole vessel circumference. Conceivably, such an analysis may have its limitations, with an increase of an adhesion molecule at one site of lesion neutralized by a decrease at another. However, results in the present study show that the mean level of adhesion molecule expression, assayed by measurements on healthy and diseased endothelium over time, show a significantly different pattern for apoE Ϫ/Ϫ and wild-type mice. ICAM-1 and PECAM-1 are adhesion molecules that are constitutively expressed, as opposed to VCAM-1, which is inducible, by vascular endothelial cells. Such differences may perhaps give a clue to the results that have been obtained in the present study. Great care should be taken in evaluating the role of these adhesion molecules, inasmuch as a number of other adhesion molecules, such as P-selectin and E-selectin, have not been taken in consideration in the present study. 49 In addition, caution has to be taken in extrapolating results from mice to humans because of the considerable differences in genetic, metabolic, and other pathways leading to atherosclerosis. Indeed, an absence of cholesteryl ester transfer protein and Lp(a) is observed in mice. Moreover, most studies in mice are performed on the aorta instead of the coronary arteries. Genes implicated in diseased coronaries are thought to differ from those implicated in aortic lesions. 50 In conclusion, our results suggest that ICAM-1, PECAM-1, and VCAM-1 expressions may provide a background to the atherosclerotic plaque formation in this model. Specifically, they would greatly facilitate monocyte adhesion to the endothelium and subsequent extravasation. However, the complexity of the interplay of biomechanical and humoral stimuli in the induction and modulation of adhesion molecules and their cofactors remains far from being clear. Expressions of these adhesion molecules in knockout animals were correlated with the evolution of the plaque from a fatty to a fibrous stage.
